Evidence map›Paper›PMID 42198666›Full record

ArticlePathogens (Basel, Switzerland)2026

Early Regulatory and Th2-Associated Responses Shape Resistance to

Lizzi Herrera, Carlos M Restrepo, Rodrigo Villalobos, Kissy Degracia, Jennifer Álvarez, Patricia L Fernández

Abstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lizzi HerreraCentro de Biología Celular y Molecular de Enfermedades, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP), Ciudad del Saber, Panama City 7144, Panama.ORCID 0000-0002-1867-8181
Carlos M RestrepoCentro de Biología Celular y Molecular de Enfermedades, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP), Ciudad del Saber, Panama City 7144, Panama.ORCID 0000-0003-1311-1132
Rodrigo VillalobosDepartamento de Patología, Hospital Santo Tomás, Panama City 7127, Panama.
Kissy DegraciaEscuela de Biotecnología, Facultad de Ciencias de la Salud Dr. William C. Gorgas, Universidad Latina de Panamá, Panama City 7155, Panama.
Jennifer ÁlvarezEscuela de Biología, Facultad de Ciencias Naturales, Exactas y Tecnología, Universidad de Panamá, Panama City 7156, Panama.
Patricia L FernándezCentro de Biología Celular y Molecular de Enfermedades, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP), Ciudad del Saber, Panama City 7144, Panama.ORCID 0000-0002-0762-0566

Funding

Secretaría Nacional de Ciencia, Tecnología e Innovación NI-03-2017Sistema Nacional de Investigación SNI-142-2018Sistema Nacional de Investigación SNI-160-2017
6 · The paper itself

Abstract

Characterizing the specific interactions of

Indexed as

Disease ResistanceLeishmania guyanensisLeishmaniasisTh2 CellsT-Lymphocytes, RegulatoryAnimalsCytokinesDisease Models, AnimalFemaleMiceMice, Inbred BALB CMice, Inbred C57BLTh1 CellsCytokinesBALB/cC57BL/6cytokinesL. panamensisTh1/Th2 paradigm

Identifiers

PMID42198666
PMCPMC13209690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.